Stifel Initiates Coverage On Pyxis Oncology With Buy Rating, Announces Price Target of $10
Stifel Initiates Coverage On Pyxis Oncology With Buy Rating, Announces Price Target of $10
Stifel對Pyxis Oncology的股票發起買入覆蓋,宣佈目標價格爲10美元。
Stifel analyst Bradley Canino initiates coverage on Pyxis Oncology (NASDAQ:PYXS) with a Buy rating and announces Price Target of $10.
Stifel分析師Bradley Canino開始對Pyxis Oncology (納斯達克股票代碼:PYXS) 進行覆蓋,並給出買入評級,宣佈目標價爲10美元。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。